COM:EFFECTOR
eFFECTOR Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
effector.com/crunchbase
effector-therapeuticslinkedin
effector-therapeuticsfounding date
Jan 01, 2012ipo date
Mar 01, 2021
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company ...Show More